Changes in US stocks | Weight loss drug concept rises, LLY.US (LLY.US) rises more than 4% to break record high

Zhitongcaijing · 5d ago

The Zhitong Finance App learned that on Wednesday, the concept of diet pills increased. Lilly (LLY.US) rose more than 4% to break a record high, Amgen (AMGN.US) rose more than 3%, and Novo Nordisk (NVO.US) and PFE.US (PFE.US) rose more than 1%. According to the news, it is reported that Eli Lilly is close to reaching a deal to acquire Ventyx Biosciences for more than $1 billion to expand its R&D pipeline in the field of inflammatory bowel disease and neurodegenerative diseases. The deal may be announced soon. Additionally, UBS maintained Eli Lilly's stock purchase rating and raised its target price to $1,250.